Skip to content

Clinical study on monitoring the sedation level of ciproflol based on sedline original EEG

Clinical study on monitoring the sedation level of ciproflol based on sedline original EEG

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094266
Enrollment
Unknown
Registered
2024-12-19
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacodynamic study of sedative drugs induced changes in consciousness

Interventions

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. 40 healthy subjects aged 18-45 years old; 2. BMI between 18-26; 3. American Society of anesthesiologists (ASA) grade I; 4. Understand and voluntarily participate in the study, and sign the informed consent form by himself;

Exclusion criteria

Exclusion criteria: 1. Drug abuse or alcohol abuse; 2. Have psychiatric or neurological diseases or medical history; 3. Allergy to propofol or other emulsion injections; 4. History of cardiovascular, respiratory, renal, hepatic, gastrointestinal diseases or major surgery; 5. Participated in other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
EEG parameters;

Secondary

MeasureTime frame
Modified Observer"s Assessment of Alertness/Sedation, MOAA/S;

Countries

China

Contacts

Public ContactYaomin Zhu

The First Affiliated Hospital of Xi'an Jiaotong University

zhuyaomin_mzk@163.com+86 18629382846

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026